Albumin Creatinine Ratio: What Your Number Means
UACR under 30 mg/g is normal, 30-300 mg/g signals moderately increased albuminuria, and above 300 mg/g is severely increased, an early marker of kidney damage.
Urine Albumin Creatinine (Lab Test)
8 source-based articles maintained by the HealthRX.com Editorial Team.
8articles
3topic areas covered
May 26, 2026latest review
Urine Albumin Creatinine (Lab Test) library
Showing 8 of 8 clinical reviews.
Albumin Creatinine Ratio: What Your UACR Number Means
UACR under 30 mg/g is normal, 30-300 mg/g signals moderately increased albuminuria, above 300 mg/g is severely increased. Learn what your result means.
Albumin/Creatinine Ratio: When Is Treatment Discussed?
A confirmed UACR of 30 mg/g or higher (KDIGO A2) is the threshold where treatment options are typically discussed, after confirming the result.
UACR Normal Range: Under 30 mg/g vs Optimal Under 10
UACR under 30 mg/g is labeled normal, but risk rises below that. Learn why some clinicians target under 10 mg/g and what your number means.
Urine Albumin-Creatinine Ratio: Which Tests to Order Alongside UACR
A clinical guide to the urine albumin-creatinine ratio (UACR), normal ranges, what results mean, and which paired lab tests maximize kidney and cardiometabolic screening.
Urine Albumin/Creatinine Ratio: Drugs That Distort This Test
A clinical guide to the urine albumin-to-creatinine ratio (UACR): what it measures, normal ranges, drugs that can raise or lower results without true kidney change, and how to interpret a single value correctly.
Urine Albumin/Creatinine Ratio: Evidence-Based Ways to Improve This Number
Learn what your urine albumin/creatinine ratio means, what a normal range looks like, and which diet, medication, and lifestyle strategies have the strongest clinical evidence for lowering it.
Urine Albumin/Creatinine Ratio: What Your Number Changes About Your Treatment
Learn what your urine albumin/creatinine ratio (uACR) means, what the normal range is, and exactly how each result category triggers different clinical decisions for diabetes, hypertension, and kidney disease management.